Target intelligence / Profile preview

Calponin 2 pseudogene 12 (CNN2P12)

Target
CNN2P12
Molecular classification
Other (Pseudogene)
01

Overview

Calponin 2 pseudogene 12 (CNN2P12) is designated as a **pseudogene** of the calponin 2 (CNN2) gene family. Pseudogenes are non-coding DNA sequences similar to functional genes but typically lack the ability to encode a functional protein due to disabling mutations or truncations. There are several CNN2-related pseudogenes annotated in the human genome, present on various chromosomes[5]. CNN2P12 does not code for a functional protein and is not a recognized therapeutic target, enzyme, receptor, or transporter. It is not known to play a role in disease, biological processes, or drug interactions. It should not be confused with the protein-coding calponin 2 (CNN2) gene, which is involved in actin filament regulation, smooth muscle contraction, and cell adhesion[1][5]. Clarification: CNN2P12 is a **pseudogene** and not a functional protein, receptor, or target. Search results refer to multiple CNN2 pseudogenes but provide no evidence that CNN2P12 itself encodes a protein or has therapeutic relevance[5][4]. The canonical therapeutic target is **calponin 2** (abbreviation: CNN2), but **CNN2P12** does not meet those criteria. If you require information on the *functional* calponin 2 protein and its role in biology or disease, see the entries for the gene **CNN2**, not CNN2P12[1][5].

Other names
CNN2P12calponin 2 pseudogene 12

Beyond the preview

Go deeper on Calponin 2 pseudogene 12 (CNN2P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calponin 2 pseudogene 12 (CNN2P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call